Siemens Healthineers and University of Miami Health System Enter Value Partnership Agreement to Transform Healthcare

Siemens HealthineersSiemens Healthineers and UHealth - University of Miami Health System - announced a Value Partnership(1) agreement. This strategic relationship will further technological advancement and standardization of equipment at the health system, while allowing the university to create educational and training programs for clinicians and technologists. This unique agreement is the first of its kind in Florida.

Through this planned ten-year agreement, UHealth will acquire the latest medical technology equipment from both Siemens Healthineers and Varian, a Siemens Healthineers company, which will help expand diagnostic and therapeutic treatments. Other aspects of the Value Partnership include educational and service offerings, digital health technology and consulting services.

Also, through the collaboration, new clinical and operational strategies will be developed and deployed to evolve care, enhance diagnosis, and improve the overall health of Floridians.

"Building new clinical structures over the next few years, our goal is to incorporate the latest technological advances to serve our patients," said Alexander McKinney, M.D., chair of the Department of Radiology at the University of Miami Health System. "We look forward to working with the team at Siemens Healthineers."

In conjunction with adding world-class medical technology equipment at UHealth's various locations throughout Florida, technology from Siemens Healthineers will be used in training the next generation of physicians.

"Our equipment and solutions will be a great addition to the University of Miami Health System's already rapidly expanding footprint, allowing it to expand its educational and training offerings across the region," said David Pacitti, president and head of the Americas, Siemens Healthineers. "This Value Partnership is a proof point of the unbroken, strong demand for Siemens Healthineers’ products, services and solutions in the North American market."

Financial terms were not disclosed.

Through the "Value Partnership" partnership model, hospitals can optimize business processes, expand capabilities and drive innovation. These partnerships rely on the entire Siemens Healthineers portfolio to create added value beyond equipment.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion.

1. Value Partnership is a branded enterprise service offering from Siemens Healthineers. The term "Value Partnership" does not imply, create, and/or establish a legal partnership or joint venture between Siemens Healthineers and the University of Miami Health System.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...